Clinical Trials Directory

Trials / Completed

CompletedNCT02945787

Spanish-Language Smoking Cessation Trial

Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-Language Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,417 (actual)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Results of a recently completed National Cancer Institute (NCI) funded trial of an intervention, Forever Free: Stop Smoking for Good, revealed high efficacy throughout the 24- month follow-up period, further supporting the utility of extended self-help for promoting and maintaining tobacco abstinence. Investigators have recognized that wide-scale implementation, and therefore public health impact, would be enhanced by the availability of a Spanish-language version to reach the largest and fastest growing ethnic minority population of smokers. The goal of this study is to address this gap by testing a Spanish-language version of the validated self-help smoking cessation intervention. If demonstrated effective, the proposed intervention would represent an easily disseminable and low-cost intervention with significant public health impact for Hispanic/Latino smokers throughout the United States. The aims of this project are to test the efficacy of a Spanish-language version of a validated, extended self-help intervention for smoking cessation among Spanish-speaking smokers against usual care control. Participants (N = 1400) recruited nationally will be randomized to the two arms.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSpanish-Language Version of the Stop Smoking for GoodParticipants in the first arm will receive the Spanish-language version of the Stop Smoking for Good (SS-SP) intervention distributed over 18 months.
BEHAVIORALNCI-Produced Spanish-language Self-help BookletParticipants in the second arm will receive a single, credible, NCI-produced Spanish-language self-help booklet.

Timeline

Start date
2016-10-24
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2016-10-26
Last updated
2022-11-04
Results posted
2021-09-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02945787. Inclusion in this directory is not an endorsement.